Clinical Trial - HPV Oropharyngeal Cancer, Medical University of South Carolina
Summary
ClinicalTrials.gov published a registry entry for a new clinical trial (NCT07513389) investigating HPV-positive oropharyngeal cancer at the Medical University of South Carolina (MUSC). The study documents participant enrollment information, eligibility criteria, and research objectives. This registry entry provides transparency into ongoing federally-funded and regulated clinical research.
What changed
A clinical trial registration entry was published on ClinicalTrials.gov documenting a Phase 2/Phase 3 interventional study for HPV-positive oropharyngeal cancer conducted by MUSC researchers. The registry entry includes standard clinical trial information such as study design, participant age range, inclusion/exclusion criteria, and primary outcome measures.
Healthcare providers and clinical investigators should note this trial as part of ongoing research in head and neck oncology. Patients meeting eligibility criteria may benefit from enrollment consideration. This registry entry does not create compliance obligations but supports transparency requirements under clinical research registration policies.
What to do next
- Monitor study status for enrollment updates
- Review eligibility criteria if considering patient referral
Source document (simplified)
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.